50242-060Level 3
Avastin (bevacizumab)
**Product type:** Human Prescription Drug
**Active ingredient:** BEVACIZUMAB
**Strength:** 100 mg/4mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA125085)
**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
GET
/api/v1/systems/ndc_fda/nodes/50242-060Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.